InvestorsHub Logo
Followers 49
Posts 4433
Boards Moderated 0
Alias Born 03/20/2012

Re: brando5 post# 1836

Wednesday, 05/27/2015 6:02:13 PM

Wednesday, May 27, 2015 6:02:13 PM

Post# of 3108
Clarification just issued in another filing;



Dr. Mazzo states: “[T]he money that this [$17.7 million grant] brings will allow us to advance through Phase III and to bring this therapy to market . . . .” To clarify, use of any of the grant funds from the California Institute for Regenerative Medicine is subject to dollar-for-dollar match funding by the Company. In addition, as disclosed in the Company’s Form 10-Q for the quarterly period ended March 31, 2015, filed with the SEC on May 6, 2015, the Intus Phase 3 study is expected to cost approximately $43 million.


Probably reason why company is looking to raise some money, as they have to match grant dollar for dollar.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LSTA News